Updates on the Treatment of Erythrodermic Psoriasis

Overview

Journal Psoriasis (Auckl)

Publisher Dove Medical Press

Date 2021 Jun 17

PMID 34136373

Citations 16

Authors

Yang Lo

Tsen-Fang Tsai

Affiliations

Soon will be listed here.

Abstract

Erythrodermic psoriasis (EP) is a rare variant of psoriasis, which is potentially life threatening and often resistant to conventional therapy. Biologics have revolutionized the treatment of plaque-type psoriasis, and shown promise in EP. However, due to the lack of head-to-head studies and the rarity of EP, no high level evidence-based treatment guidelines for EP have been established, and the evidence of treatment of EP is limited to case reports or small case series. Here, we present a narrative review focusing on the up-to-date information for the treatment of EP.

Citing Articles

Naturally derived bioactive compounds as precision modulators of immune and inflammatory mechanisms in psoriatic conditions.

Radu A, Tit D, Endres L, Radu A, Vesa C, Bungau S Inflammopharmacology. 2024; 33(2):527-549.

PMID: 39576422 PMC: 11842495. DOI: 10.1007/s10787-024-01602-z.

Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments.

Pang Y, Nguyen W, Guerrero L, Chrisman L, Hooper M, McCarthy M Am J Clin Dermatol. 2024; 25(6):927-950.

PMID: 39348008 DOI: 10.1007/s40257-024-00886-9.

Biologic anti-IL17 drugs in erythrodermic psoriasis.

Falco A, Mugheddu C, Anedda J, Pizzatti L, Tatti A, Conti B JAAD Int. 2024; 16:257-263.

PMID: 39253694 PMC: 11382201. DOI: 10.1016/j.jdin.2024.05.007.

An unusual acute erythrodermic rash.

Naworski W, Shedd A, Shedd A, Chou E J Am Coll Emerg Physicians Open. 2024; 5(5):e13259.

PMID: 39206251 PMC: 11350216. DOI: 10.1002/emp2.13259.

Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up.

Song B, Liu X, Jin H Clin Cosmet Investig Dermatol. 2024; 17:1811-1814.

PMID: 39139845 PMC: 11319092. DOI: 10.2147/CCID.S471582.

References

Trovato E, Orsini C, Russo F, Cortonesi G, Rubegni P . Ixekizumab as treatment of erythrodermic psoriasis. Dermatol Ther. 2021; 34(2):e14868. DOI: 10.1111/dth.14868. View

Richetta A, Maiani E, Carlomagno V, Carboni V, Mattozzi C, Giancristoforo S . Treatment of erythrodermic psoriasis in HCV+ patient with adalimumab. Dermatol Ther. 2009; 22 Suppl 1:S16-8. DOI: 10.1111/j.1529-8019.2009.01266.x. View

Deeva I, Mariani S, De Luca C, Pacifico V, Leoni L, Raskovic D . Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease. Cytokine. 2009; 49(2):163-70. DOI: 10.1016/j.cyto.2009.09.014. View

Ling M . Acitretin: optimal dosing strategies. J Am Acad Dermatol. 1999; 41(3 Pt 2):S13-7. DOI: 10.1016/s0190-9622(99)70360-9. View

Kharaeva Z, Gostova E, De Luca C, Raskovic D, Korkina L . Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients. Nutrition. 2008; 25(3):295-302. DOI: 10.1016/j.nut.2008.08.015. View

Kokelj F, Plozzer C, Torsello P, Trevisan G . Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports). J Eur Acad Dermatol Venereol. 1998; 11(2):177-9. View

Mrowietz U, Domm S . Systemic steroids in the treatment of psoriasis: what is fact, what is fiction?. J Eur Acad Dermatol Venereol. 2012; 27(8):1022-5. DOI: 10.1111/j.1468-3083.2012.04656.x. View

Yamasaki K, Nakagawa H, Kubo Y, Ootaki K . Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study. Br J Dermatol. 2016; 176(3):741-751. DOI: 10.1111/bjd.14702. View

Ahdout J, Mandel H, Chiu M . Erythroderma in a patient taking acitretin for plaque psoriasis. J Drugs Dermatol. 2008; 7(4):391-4. View

10.

Geilen C, Tebbe B, Garcia Bartels C, Krengel S, Orfanos C . Successful treatment of erythrodermic psoriasis with mycophenolate mofetil. Br J Dermatol. 1998; 138(6):1101-2. DOI: 10.1046/j.1365-2133.1998.02296.x. View

11.

Saraceno R, Talamonti M, Galluzzo M, Chiricozzi A, Costanzo A, Chimenti S . Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: a report of two cases. Case Rep Dermatol. 2013; 5(3):254-9. PMC: 3806693. DOI: 10.1159/000348645. View

12.

Zhang P, Chen H, Duan Y, Wang W, Zhang T, Li J . Analysis of Th1/Th2 response pattern for erythrodermic psoriasis. J Huazhong Univ Sci Technolog Med Sci. 2014; 34(4):596-601. DOI: 10.1007/s11596-014-1322-0. View

13.

van Dooren-Greebe R, Kuijpers A, Mulder J, de Boo T, van de Kerkhof P . Methotrexate revisited: effects of long-term treatment in psoriasis. Br J Dermatol. 1994; 130(2):204-10. DOI: 10.1111/j.1365-2133.1994.tb02901.x. View

14.

Sano S, Kubo H, Morishima H, Goto R, Zheng R, Nakagawa H . Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study. J Dermatol. 2018; 45(5):529-539. PMC: 5947137. DOI: 10.1111/1346-8138.14294. View

15.

Arcilla J, Joe D, Kim J, Kim Y, Truong V, Jaipaul N . Erythrodermic Psoriasis Treated with Apremilast. Dermatol Reports. 2016; 8(1):6599. PMC: 5134687. DOI: 10.4081/dr.2016.6599. View

16.

Mateu-Puchades A, Santos-Alarcon S, Martorell-Calatayud A, Pujol-Marco C, Sanchez-Carazo J . Erythrodermic psoriasis and secukinumab: Our clinical experience. Dermatol Ther. 2018; 31(4):e12607. DOI: 10.1111/dth.12607. View

17.

Charbit L, Mahe E, Phan A, Chiaverini C, Boralevi F, Bourrat E . Systemic treatments in childhood psoriasis: a French multicentre study on 154 children. Br J Dermatol. 2015; 174(5):1118-21. DOI: 10.1111/bjd.14326. View

18.

Moy A, Murali M, Kroshinsky D, Duncan L, Nazarian R . Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis. JAMA Dermatol. 2015; 151(7):753-60. DOI: 10.1001/jamadermatol.2015.2. View

19.

Pang M, Murase J, Koo J . An updated review of acitretin--a systemic retinoid for the treatment of psoriasis. Expert Opin Drug Metab Toxicol. 2008; 4(7):953-64. DOI: 10.1517/17425255.4.7.953. View

20.

Chen L, Tsai T . HLA-Cw6 and psoriasis. Br J Dermatol. 2017; 178(4):854-862. DOI: 10.1111/bjd.16083. View